J Diabetes Investig 7 (Suppl 1): 6469
We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article
A second study suggests the cardiovascular benefits of GLP-1 drugs may operate through mechanisms independent of weight reduction, a finding with potentially significant implications for how physicians manage patients on these medications
Finally, a higher BMI changes the uterine lining which can make it harder for an embryo to attach and therefore increases the risk of miscarriage, she added
The success of GLP1 weight-loss drugs such as Ozempic and Mounjaro comes down to appetite control and metabolic balance
Lots of research suggests such medications must be used indefinitely to maintain weight loss and related health benefits